Addex Therapeutics Stock Alpha and Beta Analysis

ADXN Stock  USD 8.65  0.15  1.76%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Addex Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Addex Therapeutics over a specified time horizon. Remember, high Addex Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Addex Therapeutics' market risk premium analysis include:
Sharpe Ratio
Expected Return
Please note that although Addex Therapeutics alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, Addex Therapeutics did 0.06  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Addex Therapeutics stock's relative risk over its benchmark. Addex Therapeutics has a beta of 0.05  . As returns on the market increase, Addex Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Addex Therapeutics is expected to be smaller as well. At this time, Addex Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 15th of June 2024, Price Fair Value is likely to grow to 346.47, while Book Value Per Share is likely to drop 0.01.

Enterprise Value

541.52 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Addex Therapeutics Backtesting, Addex Therapeutics Valuation, Addex Therapeutics Correlation, Addex Therapeutics Hype Analysis, Addex Therapeutics Volatility, Addex Therapeutics History and analyze Addex Therapeutics Performance.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.

Addex Therapeutics Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Addex Therapeutics market risk premium is the additional return an investor will receive from holding Addex Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Addex Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Addex Therapeutics' performance over market.
α0.06   β0.05

Addex Therapeutics expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Addex Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Addex Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Addex Therapeutics Market Price Analysis

Market price analysis indicators help investors to evaluate how Addex Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Addex Therapeutics shares will generate the highest return on investment. By understating and applying Addex Therapeutics stock market price indicators, traders can identify Addex Therapeutics position entry and exit signals to maximize returns.

Addex Therapeutics Return and Market Media

The median price of Addex Therapeutics for the period between Sun, Mar 17, 2024 and Sat, Jun 15, 2024 is 11.05 with a coefficient of variation of 43.39. The daily time series for the period is distributed with a sample standard deviation of 5.55, arithmetic mean of 12.79, and mean deviation of 4.37. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
Addex stock climbs on launch of new company, Neurosterix
Addex Therapeutics Ltd Short Interest Update - Defense World
ADXN Stock Earnings Addex Therapeutics Reported Results for Q4 2023
Johnson Johnson-Partnered Addex Therapeutics Epilepsy Candidate Fails Mid-Stage Study, Stock Tanks
Investment Analysis and Advice - Stock Traders Daily
ADXN Stock Earnings Addex Therapeutics Reported Results for Q1 2024

About Addex Therapeutics Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Addex or other stocks. Alpha measures the amount that position in Addex Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding40.6153.5334.2332.52
PTB Ratio231.12107.09329.97346.47

Addex Therapeutics Upcoming Company Events

As portrayed in its financial statements, the presentation of Addex Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Addex Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Addex Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Addex Therapeutics. Please utilize our Beneish M Score to check the likelihood of Addex Therapeutics' management manipulating its earnings.
4th of April 2024
Upcoming Quarterly Report
9th of May 2024
Next Financial Report
31st of December 2023
Next Fiscal Quarter End
4th of April 2024
Next Fiscal Year End
30th of September 2023
Last Quarter Report
31st of December 2022
Last Financial Announcement

Build Portfolio with Addex Therapeutics

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Information and Resources on Investing in Addex Stock

When determining whether Addex Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Addex Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Addex Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Addex Therapeutics Stock:
Check out Addex Therapeutics Backtesting, Addex Therapeutics Valuation, Addex Therapeutics Correlation, Addex Therapeutics Hype Analysis, Addex Therapeutics Volatility, Addex Therapeutics History and analyze Addex Therapeutics Performance.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Addex Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Addex Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Addex Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...